Pursuit Vascular, Inc.

22 articles about Pursuit Vascular, Inc.

• ICU Medical, Inc. to Acquire Pursuit Vascular, Inc.

  11/4/2019

  Upfront purchase price is $75 million with a potential earn-out payment in 2021

• Pursuit Vascular Announces Participation at American Society of Nephrology Annual Meeting

  10/30/2019

  Pursuit Vascular, Inc., manufacturer of ClearGuard® HD Antimicrobial Barrier Caps, today announced the company will be exhibiting at the American Society of Nephrology (ASN) Scientific Exposition taking place in Washington DC next week.

• Pursuit Vascular Announces Attendance at NRAA 2019 Annual Conference

  9/30/2019

  Pursuit Vascular, Inc., manufacturer of ClearGuard® HD Antimicrobial Barrier Caps, announced it will be exhibiting at this week's National Renal Administrators Association 2019 Annual Conference.

• Pursuit Vascular's ClearGuard HD Caps Recommended for Preventing Bloodstream Infection

  8/13/2019

  The July edition highlights the significant reduction in central-line associated bloodstream infection rates using ClearGuard HD caps vs. other commonly used caps.

• Pursuit Vascular to Exhibit at APIC 2019 Infection Control Annual Meeting

  6/10/2019

  Pursuit Vascular, Inc., manufacturer of ClearGuard® HD Antimicrobial Barrier Caps, announced it will be featuring the company's ClearGuard HD cap at APIC 2019, the Association for Infection Control and Epidemiology annual meeting taking place June 12-14 in Philadelphia, PA.

• Pursuit Vascular Invited to Present to CDC

  6/3/2019

  Pursuit Vascular, Inc., manufacturer of ClearGuard® HD Antimicrobial Barrier Caps, was invited to present to the Centers for Disease Control (CDC) Division of Healthcare Quality Promotion (DHQP) at their headquarters in Atlanta, Georgia

• Pursuit Vascular Announces Attendance at ANNA 2019 National Symposium

  4/10/2019

  Pursuit Vascular, Inc., manufacturer of ClearGuard® HD Antimicrobial Barrier Caps, announced it will be exhibiting at the American Nephrology Nurses Association 2019 National Symposium taking place in Dallas, Texas next week.

• Pursuit Vascular Announces CE Mark Approval for ClearGuard HD Caps

  4/3/2019

  Pursuit Vascular, Inc., manufacturer of ClearGuard® HD Antimicrobial Barrier Caps, today announced that the company has received both Conformité Européene (CE) Mark and Medical Device Single Audit Program (MDSAP) certificates for its ClearGuard HD caps, paving the way for launch in international markets. 

• Pursuit Vascular Announces Attendance at Renal Physicians Association 2019 Annual Meeting

  3/25/2019

   Pursuit Vascular, Inc., manufacturer of ClearGuard® HD Antimicrobial Barrier Caps, today announced it will be exhibiting at the Renal Physicians Association 2019 Annual Meeting in Chicago, March 28-30, 2019. 

• Pursuit Vascular's ClearGuard® HD Caps Selected as Top Infection Control Product for 2019

  2/12/2019

  Pursuit Vascular, Inc., manufacturer of ClearGuard® HD Antimicrobial Barrier Caps, announced that Becker's Hospital Review selected ClearGuard HD caps as one of its "100 Infection Control Products to Know" for 2019, marking the third year in a row for the innovative caps to be named to this distinguished list.

• Pursuit Vascular Announces Patent Notice of Allowance for its ClearGuard HD Antimicrobial Barrier Caps

  11/27/2018

  - Further strengthens patent portfolio

• Pursuit Vascular Announces Participation in Upcoming Nephrology Conferences

  10/17/2018

  Pursuit Vascular, Inc. today announced it will be showcasing the company's premier ClearGuard HD cap at two nephrology conferences taking place this month.

• Pursuit Vascular Outlines Expansion Plans

  10/2/2018

   Pursuit Vascular, Inc., manufacturer of ClearGuard® HD Antimicrobial Barrier Caps, the leading antimicrobial device for catheter-based dialysis patients, today announced that the company has significantly expanded its sales and customer support organization.

• Pursuit Vascular Names Board Veteran as Executive Chair

  9/12/2018

  Pursuit Vascular, Inc. today announced that veteran board member Mr. Roy Martin, Jr. has been named Executive Chairman of the Board.

• Pursuit Vascular Achieves Milestone with Shipment of 2 Millionth Pair of ClearGuard® HD Caps

  7/10/2018

  Pursuit Vascular, Inc. reached a milestone in June with the shipment of over 2 million pairs of ClearGuard HD caps during the first 6 months of 2018, an important achievement as the company continues to bring its innovative technology to a broader patient base.

• Clinical Study Featuring Pursuit Vascular ClearGuard® HD Antimicrobial Barrier Caps Receives Prestigious Editors' Choice Award

  6/19/2018

  Pursuit Vascular, Inc. announced that publication of a clinical study in the American Journal of Kidney Diseases (AJKD)

• Second Major Study Demonstrates Superiority of ClearGuard® HD Antimicrobial Barrier Caps

  6/5/2018

  Pursuit Vascular, Inc. announced publication of a study in the Journal of American Society of Nephrology (JASN) featuring the company's ClearGuard HD Antimicrobial Barrier Cap for use in hemodialysis catheters.

• FDA Broadens ClearGuard® HD Antimicrobial Barrier Cap Indications

  5/30/2018

  - ClearGuard HD Caps Have Been Shown to Reduce Central Line-Associated Bloodstream Infections in Hemodialysis Patients

• Pursuit Vascular, Inc. Release: Major Study Confirms ClearGuard HD Antimicrobial Barrier Caps Significantly Reduce Catheter-Related Bloodstream Infection And Associated Hospitalizations

  11/11/2016

• Pursuit Vascular, Inc. Wins Medical Design Excellence Award For Clearguard HD Antimicrobial Barrier Caps

  6/16/2016